Close Menu

NEW YORK – Hologic said after the close of the market on Wednesday that its revenues for the fiscal third quarter fell nearly 4 percent year over year. The reason for the decline was the inclusion of revenue from its divested Cynosure Medical Aesthetics business in the year-ago quarter.

Hologic posted $822.9 million in total revenues for the quarter, compared to $852.4 million in the year-ago period. It handily beat the consensus Wall Street revenue estimate of $616.7 million. Excluding material acquisitions and divestitures, organic revenue grew nearly 8 percent in the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

In Science this week: chromatin accessibility of microglia during fetal development, and more.